MMP-9 Serum Levels in Schizophrenic Patients during Treatment Augmentation with Sarcosine (Results of the PULSAR Study)

Aim: Find changes in matrix metallopeptidase-9 (MMP-9) levels during augmentation of antipsychotic treatment with sarcosine and a relationship between schizophrenia symptoms severity and initial level of MMP-9. Method: Fifty-eight patients with diagnosis of schizophrenia with predominant negative sy...

Descripción completa

Detalles Bibliográficos
Autores principales: Strzelecki, Dominik, Kałużyńska, Olga, Szyburska, Justyna, Wysokiński, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964451/
https://www.ncbi.nlm.nih.gov/pubmed/27409603
http://dx.doi.org/10.3390/ijms17071075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964451/
https://www.ncbi.nlm.nih.gov/pubmed/27409603
http://dx.doi.org/10.3390/ijms17071075

Ejemplares similares